全文获取类型
收费全文 | 2005篇 |
免费 | 106篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 127篇 |
妇产科学 | 90篇 |
基础医学 | 225篇 |
口腔科学 | 60篇 |
临床医学 | 108篇 |
内科学 | 401篇 |
皮肤病学 | 44篇 |
神经病学 | 93篇 |
特种医学 | 45篇 |
外科学 | 308篇 |
综合类 | 41篇 |
一般理论 | 1篇 |
预防医学 | 89篇 |
眼科学 | 37篇 |
药学 | 138篇 |
中国医学 | 6篇 |
肿瘤学 | 227篇 |
出版年
2023年 | 8篇 |
2022年 | 30篇 |
2021年 | 66篇 |
2020年 | 29篇 |
2019年 | 31篇 |
2018年 | 43篇 |
2017年 | 33篇 |
2016年 | 49篇 |
2015年 | 58篇 |
2014年 | 76篇 |
2013年 | 85篇 |
2012年 | 131篇 |
2011年 | 137篇 |
2010年 | 63篇 |
2009年 | 64篇 |
2008年 | 126篇 |
2007年 | 116篇 |
2006年 | 115篇 |
2005年 | 124篇 |
2004年 | 101篇 |
2003年 | 87篇 |
2002年 | 65篇 |
2001年 | 51篇 |
2000年 | 57篇 |
1999年 | 37篇 |
1998年 | 15篇 |
1997年 | 16篇 |
1996年 | 9篇 |
1995年 | 12篇 |
1994年 | 9篇 |
1993年 | 12篇 |
1992年 | 33篇 |
1991年 | 23篇 |
1990年 | 13篇 |
1989年 | 17篇 |
1988年 | 15篇 |
1987年 | 27篇 |
1986年 | 21篇 |
1985年 | 17篇 |
1984年 | 8篇 |
1983年 | 12篇 |
1980年 | 9篇 |
1979年 | 10篇 |
1978年 | 5篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1973年 | 7篇 |
1972年 | 6篇 |
1967年 | 4篇 |
1966年 | 3篇 |
排序方式: 共有2117条查询结果,搜索用时 218 毫秒
41.
Colorectal cancer (CRC) is a frequently diagnosed cancer and causing significant mortality in the patients. Metastasis caused by CRC is mainly responsible for this cancer-related deaths. Despite recent advancements in the treatment methods, prognosis remains poor. Therefore, effective treatment strategies need to be designed for successful management of this disease. Dehydroepiandrostenedione (DHEA), a 17-ketosteroid hormone produced by adrenal glands, gonads and including gastrointestinal tract is required for several physiological processes. Deregulation of DHEA levels leads to various disease conditions including cancer. In fact, several experimental studies strongly suggest that DHEA could be used as a chemopreventive agent against colon cancer. Prenlyation of certain membrane proteins such as phosphatase of regenerating liver-3 (PRL-3) is crucial for metastatic progression of colon cancer cells. The ability of DHEA to target prenylation pathway could be utilized to inhibit PRL-3 prenylation for successful prevention of CRC metastases. As DHEA is a widely consumed drug for various ailments, incorporation of DHEA in the treatment regimen may be beneficial to prevent or delay the occurrence of metastasis resulting from CRC. 相似文献
42.
Kamlendra Singh Bhadoriya Mukesh C. Sharma Shailesh V. Jain Ganesh S. Raut Jyotsna R. Rananaware 《Medicinal chemistry research》2013,22(5):2312-2327
The discovery of clinically relevant antagonists of TRPV1 for neuropathy pain therapy has proven to be a challenging task. For better understanding of the molecular interactions of antagonists with TRPV1 receptor, a series of chroman and tetrahydroquinoline ureas were analyzed by k-nearest neighbor molecular field analysis (kNN-MFA) and molecular docking. To elucidate the structural properties required for activity as TRPV1 antagonists, we report here kNN-MFA-based 3D-QSAR model for chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists. Sphere exclusion method was used for dividing the compounds into training (26 compounds) and test (5 compounds) set. Overall model classification accuracy was 81.35 % (q 2 = 0.8135, representing internal validation) in training set and 81.44 % (pred_r 2 = 0.8144, representing external validation) in test set using stepwise forward as a method of variable selection. The stereo view of molecular rectangular grid field of 3D-QSAR using this approach showed that steric and hydrophobic effects dominantly determine binding affinities. Furthermore, the crystal structure of TRPV1 was obtained from protein data bank (PDB code 2NYJ, resolution 3.20 Å), and docking of 31 TRPV1 antagonists into putative binding sites of the TRPV1 were studies. Molecular docking was employed to explore the binding mode between these compounds and the receptor, as well as help understanding the structure–activity relationship revealed by kNN-MFA. Our QSAR model and molecular docking results corroborate with each other and propose directions for the design of new antagonists with better activity toward TRPV1. 相似文献
43.
44.
Visceral leishmaniasis (VL) remains a major health problem in old world, and India accounts for half of the world burden. The widespread emergence of resistance to standard drug in India poses a major obstacle in the control of leishmaniasis. Post-Kala-Azar dermal leishmaniasis (PKDL) is considered as main source of drug resistance. Experimental data indicate that resistance against newer drugs is also imminent. Therefore, in vitro studies were carried out to test minimum parasiticidal concentration of five conventional and newly introduced anti-leishmanial drugs against 20 field isolates of Leishmania donovani obtained from visceral and post-Kala-Azar dermal leishmaniasis patients of India. Study revealed wide range of variation in minimum inhibitory concentration of sodium antimony gluconate (SAG). PKDL isolates displayed significantly lower susceptibility to SAG and miltefosine than VL isolates with P value of 0.0006 and 0.0243, respectively. All clinical isolates had higher IC50 value for paromomycin and miltefosine as compared to reference strain indicating their vulnerability to develop unresponsiveness. However, isolates were uniformly susceptible to pentamidine and amphotericin B. The results of gene expression analysis of AQP1 were largely in agreement with phenotypic drug sensitivity results. Interestingly, significant down-regulation of AQP1 was observed in PKDL isolates as compared to VL isolates indicating their increased propensity for drug unresponsiveness. However, no significant difference in mRNA expression of LdMT and LdRos3 gene was found for two groups. The present study unravels valuable baseline scientific data showing variation in the drug susceptibility pattern in the L. donovani isolates. The information might have impact on the management and control of Indian visceral leishmaniasis. 相似文献
45.
Andreas Jaehne Thomas Unbehaun Bernd Feige Ulrich C. Lutz Anil Batra Dieter Riemann 《Sleep medicine》2012,13(10):1286-1292
ObjectiveSubjective quality of sleep is impaired in smokers compared with non-smokers, but there is only limited evidence from methodologically sound studies about differences in polysomnography (PSG) sleep characteristics. Therefore, this study used PSG to evaluate sleep in smokers and non-smokers while controlling for other parameters that affect sleep.MethodsAfter an adaptation night, PSG sleep laboratory data were obtained from 44 smokers (29 men and 15 women, median age 29.6 years) and compared with PSG data from 44 healthy, sex- and age-matched never smokers. Exclusion criteria were alcohol or other substance abuse, psychiatric or endocrine diseases, and treatment with any kind of psychotropic medication. Nicotine and cotinine plasma levels were measured (in the smoking group) and subjective sleep quality assessed in both groups.ResultsThe smokers had a Fagerström tolerance score of 6.4, consumed an average of 21.2 cigarettes per day and had been smoking for 13.1 years (median). Smokers had a shorter sleep period time, longer sleep latency, higher rapid eye movement sleep density, more sleep apneas and leg movements in sleep than non-smokers. There were no differences regarding parameters of spectral analysis of the sleep electroencephalogram as well as in the sleep efficiency measured by PSG. Nevertheless smokers rated their sleep efficiency lower on the Pittsburgh Sleep Quality Index compared with non-smoking individuals, but no differences were detected on the SF-A. Plasma cotinine level correlated negatively with slow wave sleep in the smoking group.ConclusionsSmokers showed a number of insomnia-like sleep impairments. The findings suggest that it is important for sleep researchers to control smoking status in their analyses. Further research should focus on the causes and consequences of impaired sleep during tobacco cessation, as sleep disturbances are a known risk factor for early relapse after initial tobacco abstinence. 相似文献
46.
Runjan Chetty Pelvender Gill Parassar Mugon Jyotsna Shrimankar Caroline Hughes 《Virchows Archiv : an international journal of pathology》2012,461(5):483-487
We wish to highlight the unusual occurrence of gastric neuroendocrine cell hyperplasia and type I neuroendocrine tumours within three hyperplastic polyps. In all cases, the neuroendocrine component was present within and between the hyperplastic foveolar glands of the polyps and overall formed the minor part of the polyps. Two of the patients presented with epigastric pain and the other with fatigue from anaemia, and on endoscopy, all three were found to have superficially ulcerated gastric polyps in the body (cases 1 and 2) and fundus (case 3). Two of the cases had serologically proven autoimmune atrophic gastritis, while the third case had histological evidence of an atrophic gastritis, most likely also autoimmune in aetiology. Cases 1 and 3 had single hyperplastic polyps, while case 2 had three polyps. All polyps showed linear neuroendocrine cell hyperplasia within hyperplastic foveolar epithelium both at the surface and within deeper-situated glands. Neuroendocrine immunohistochemistry highlighted the neuroendocrine cell hyperplasia. The bulk of the neuroendocrine component was restricted to hyperplastic mucosa forming the polyps. Non-hyperplastic adjacent mucosa showed less prominent neuroendocrine cell hyperplasia. It is unclear whether the two pathologies occurred simultaneously or independently. The common feature and causal link is atrophic gastritis, which predisposed the gastric mucosa to the development of both neuroendocrine cell hyperplasia and tumours, and hyperplastic polyps. 相似文献
47.
Nadkarni Abhijit Vasudevan Pavitra Krishnakumar Jyotsna 《Archives of women's mental health》2022,25(3):667-670
Archives of Women's Mental Health - ‘Indigenous peoples’ across the globe suffer a disproportionate burden of mental illness. However, this burden is not fully explored in India... 相似文献
48.
49.
50.